Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. (CCRN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ccrn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cross Country Healthcare, Inc. (CCRN) measures how much investors pay for each dollar of the company's trailing earnings. CCRN's current PE ratio of N/A is calculated by dividing its stock price of $13.18 by its TTM earnings per share of -$3.13.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 10 fiscal years · Front-end computedMinQ1 · 25%30.3x
MedianQ3 · 75%116.9x
Max
At N/A, CCRN's current P/E is lower than in 0% of its annual fiscal year readings over the past 10 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cross Country Healthcare, Inc.You CCRN | $426M | N/A | — | -$3.13 |
 Agilon Health, Inc. AGL | $1.6B | N/A | — | -$24.48 |
 Auna S.A. AUNA | $338M | 5.10x | -89.7% | $3.24 |
 Enhabit, Inc. EHAB | $707M | N/A | — | -$0.09 |
 OrthoPediatrics Corp. KIDS | $468M | N/A | — | -$1.69 |
 Charming Medical Limited Class A Ordinary Shares MCTA | $446M | 98.88x | +100.0% | $0.07 |
 OptimizeRx Corporation OPRX | $96M | 44.33x | -10.3% | $0.28 |
Industry Average 3 peers with valid PE | — | 49.44x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.93 | — | |
2024-12-31 FY2024 | — | $-0.44 | — | |
2023-12-31 FY2023 | 10.96x | $2.07 | +107.3% | |
2022-12-31 FY2022 | 5.29x | $5.02 | -31.5% | |
2021-12-31 FY2021 | 7.72x | $3.60 | — | |
2020-12-31 FY2020 | — | $-0.36 | — | |
2019-12-31 FY2019 | — | $-1.61 | — | |
2018-12-31 FY2018 | — | $-0.48 | — | |
2017-12-31 FY2017 | 11.91x | $1.07 | -81.1% | |
2016-12-31 FY2016 | 62.96x | $0.25 | -46.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cross Country Healthcare, Inc. (CCRN) measures how much investors pay for each dollar of the company's trailing earnings. CCRN's current PE ratio of N/A is calculated by dividing its stock price of $13.18 by its TTM earnings per share of -$3.13.
Frequently asked questions
CCRN pe ratio · 6 questionsCCRN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $13.18 and TTM EPS of -$3.13. Data sourced from Financial Modeling Prep via CCRN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cross Country Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08